Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Home
  • News
  • Articles
  • Exclusive
  • HB Originals
  • Gallery
  • Advertisement
Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Medical Science
Search
  • Home
  • Categories
    • Medical Science
    • Health Awareness
  • Bookmarks
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
© 2025 Health Hub Media Pvt Ltd. All Rights Reserved.
Healthcare Leadership, Policy & Digital Health News India > Blog > Frontline Focus > Telangana DCA Busts Illegal Mephentermine Sales to Gym-Goers in Secunderabad

Telangana DCA Busts Illegal Mephentermine Sales to Gym-Goers in Secunderabad

Published: October 18, 2025
SHARE

The Telangana Drugs Control Administration (DCA) has uncovered the illegal sale of mephentermine sulphate injections, intended for medical use, to gym-goers in Secunderabad. This cardiac stimulant was being misused to enhance physical performance, posing serious health risks.

Glimpse:

In a recent operation, the DCA, in collaboration with Karkhana police, raided an unlicensed facility in Namalagundu, Secunderabad. They seized 66 vials of ‘Termin’ and ‘Termiva’ injections, which contain mephentermine sulphate. These injections were being sold illegally to gym-goers for bodybuilding purposes. The drugs, originally priced at ₹40 per vial, were being sold at inflated rates ranging from ₹1,000 to ₹5,000.

On October 17, 2025, officials from the Telangana Drugs Control Administration (DCA), along with the Karkhana police, conducted a raid at an unlicensed premises in Namalagundu, Secunderabad. The premises, owned by M. Naresh, were found to be illegally stocking and selling mephentermine sulphate injections ‘Termin’ and ‘Termiva’ to gym-goers for misuse in bodybuilding. These cardiac stimulant drugs are intended for medical use to treat hypotension, particularly during spinal anesthesia in surgical procedures. However, they were being sold at exorbitant prices, posing significant health risks to users.

The misuse of these injections can lead to severe cardiovascular disorders and, in extreme cases, may be fatal. Authorities also discovered that the vials were being reused among multiple users, increasing the risk of transmitting infections such as HIV. M. Naresh has been arrested, and legal proceedings are underway. The DCA has warned that if larger stocks are uncovered, additional charges, including cheating, may be imposed.

“The misuse of prescription drugs like mephentermine for performance enhancement is not only illegal but also life-threatening. We are committed to ensuring public safety and will continue our crackdown on such illicit activities.”

By

HB Team

Related News

Unihealth Expands African Footprint with Entebbe Deal, Boosts Capacity to 150 Beds

April 24, 2026

Graviti Pharma Expands South India Footprint with Strategic Karnataka Entry

April 24, 2026

Delhi Cantt Hospital Goes HighTech with Robotic Surgery Boost

April 24, 2026

Medtronic Brings Smart Brain Tech to India: A Game Changer for Parkinson’s Care

April 24, 2026

Premji Invest Backs Newera Hospitals to Expand Advanced Care Beyond Metro Cities

April 23, 2026

Venkaiah Naidu Unveils Atal MedTech Museum to Showcase India’s Healthcare Innovation Journey

April 23, 2026

Boehringer Ingelheim Launches £150M AI Hub in London to Accelerate Drug Discovery

April 23, 2026

Kotak Mahindra Bank Backs Advanced Diagnostics Upgrade at Mumbai’s Somaiya Hospital

April 23, 2026

Odisha Approves ₹3,877 Cr Investments to Accelerate Pharma and MedTech Growth

April 23, 2026

India Emerges as Global Leader in AI-Driven Healthcare Adoption

April 22, 2026

Aster CMI Introduces Karnataka’s First Dedicated Pediatric Liver ICU for Critical Care

April 22, 2026

India Launches First AI Driven Rural Medical Hub to Bridge Village Healthcare Gap

April 21, 2026

AI Meets Radiology at Scale: DeepTek and deepc Unite for Smarter Clinical Workflows

April 21, 2026

Apollo Hospitals Expands Tech-Driven Care to Sri City

April 21, 2026

Baptist Health Expands Rural Footprint with Magnolia Hospital Acquisition

April 19, 2026

New Leadership on the Horizon: CDC Eyes Stability with Erica Schwartz Nomination

April 21, 2026

eClinicalWorks CEO: Scaling AI Innovation in Healthcare Must Never Compromise Reliability or Safety

April 21, 2026

NHA Launches Digital Academy to Power India’s Next-Gen Healthcare Workforce

April 20, 2026

OpenAI Unveils GPT-Rosalind to Accelerate Drug Discovery and Life Sciences Research

April 20, 2026

Telemedicine in India: Key Rules Every Doctor Must Follow in the Digital Care Era

April 20, 2026
AWS Unveils Amazon Connect Health to Slash Administrative Burden in Healthcare
Lilly Bets Up to $2.4 Bn on Orna Therapeutics to Boost In Vivo CAR-T Breakthroughs
Tata Elxsi Launches Global ODC for Terumo to Fast-Track Cardiac & Vascular Technology Innovation
AI Upgrade Turns NHS App into Real Time Appointment Booking Hub for Millions
AstraZeneca Commits $2B to Expand Maryland Biologics Manufacturing! Doubling Capacity and Building for Rare Diseases
Your browser does not support the audio element.
Your browser does not support the audio element.

Contact us

Privacy Policy

Terms & Conditions

HealthBuzz is a leading platform for healthcare news in India, covering hospital leadership updates, health policy developments, digital health innovations, and emerging healthcare startups. Stay informed with the latest insights shaping India’s healthcare ecosystem.

Facebook Twitter Youtube Whatsapp

Quick Links

  • Home
  • Articles
  • HB Originals
  • News
  • Videos
  • Gallery

Company

  • About us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Content Complaince

Install our Mobile App for Best Experience

Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
Follow US
Health Hub Media Pvt. Ltd. © 2026 All Rights Reserved
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?